(Q37317868)

19 August 2017

1 reference

title

Neurochemical dementia diagnostics: assays in CSF and blood (English)

1 reference

19 August 2017

0 references

6

Johannes Kornhuber

1 reference

19 August 2017

Jens Wiltfang

5

0 references

Joachim Hornegger

series ordinal

2

object named as

Joachim Hornegger

1 reference

19 August 2017

1

Piotr Lewczuk

1 reference

19 August 2017

4

Markus Otto

1 reference

19 August 2017

Rüdiger Zimmermann

3

1 reference

19 August 2017

publication date

1 November 2008

1 reference

European Archives of Psychiatry and Clinical Neuroscience

19 August 2017

published in

1 reference

19 August 2017

volume

258 Suppl 5

1 reference

19 August 2017

page(s)

44-49

1 reference

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-5005-3

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-5005-3

Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-5005-3

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-5005-3

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

21 January 2018

1 reference

12 December 2020

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

1 reference

12 December 2020

Differential Level of Platelet Amyloid beta Precursor Protein Isoforms: An Early Marker for Alzheimer Disease

1 reference

12 December 2020

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.

1 reference

12 December 2020

Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities

1 reference

12 December 2020

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

1 reference

12 December 2020

The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain

1 reference

12 December 2020

Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease

1 reference

12 December 2020

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

12 December 2020

Tau protein phosphorylated at threonine 181 in CSF as a neurochemical biomarker in Alzheimer's disease: original data and review of the literature

1 reference

12 December 2020

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

12 December 2020

Low frequency of post-lumbar puncture headache in demented patients

1 reference

12 December 2020

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment

1 reference

12 December 2020

Evaluation and use of diagnostic tests in Alzheimer's disease

1 reference

12 December 2020

Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.

1 reference

12 December 2020

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.

1 reference

12 December 2020

CSF markers for incipient Alzheimer's disease

1 reference

12 December 2020

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

12 December 2020

The German Competence Net Dementias: standard operating procedures for the neurochemical dementia diagnostics

1 reference

12 December 2020

Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

1 reference

12 December 2020

Therapeutic approaches to Alzheimer's disease

1 reference

12 December 2020

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

12 December 2020

Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

1 reference

12 December 2020

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

1 reference

12 December 2020

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

1 reference

12 December 2020

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

1 reference

12 December 2020

Alzheimer's disease-do tauists and baptists finally shake hands?

1 reference

12 December 2020

Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.

1 reference

12 December 2020

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

1 reference

12 December 2020

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

1 reference

12 December 2020

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

12 December 2020

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke

1 reference

12 December 2020

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease

1 reference

12 December 2020

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study

1 reference

12 December 2020

Defective brain microtubule assembly in Alzheimer's disease

1 reference

12 December 2020

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease

1 reference

12 December 2020

Amyloid-associated depression: a prodromal depression of Alzheimer disease?

1 reference

12 December 2020

Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.

1 reference

12 December 2020

Neurochemical dementia diagnostics: State of the art and research perspectives

1 reference

12 December 2020

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

12 December 2020

Cerebrospinal fluid markers for prediction of Alzheimer's disease

1 reference

12 December 2020

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

12 December 2020

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

1 reference

12 December 2020

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay

1 reference

12 December 2020

Electrophoretic separation of amyloid beta peptides in plasma.

1 reference

12 December 2020

Neurochemical diagnosis of Alzheimer's dementia by CSF Abeta42, Abeta42/Abeta40 ratio and total tau.

1 reference

12 December 2020

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

1 reference

12 December 2020

International quality control survey of neurochemical dementia diagnostics.

1 reference

12 December 2020

Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.

1 reference

12 December 2020

The carboxyl termini of beta-amyloid peptides 1-40 and 1-42 are generated by distinct gamma-secretase activities

1 reference

12 December 2020

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

1 reference

12 December 2020

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

1 reference

12 December 2020

10.1007/S00406-008-5005-3

Identifiers

DOI

1 reference

19 August 2017

1 reference